Print Page     Close Window     

SEC Filings

10-K
BIOTIME INC filed this Form 10-K on 03/16/2017
Entire Document
 

A summary of LifeMap Sciences’ Equity Incentive Plan activity follows (in thousands except weighted average exercise price):

   
Shares
Available
for Grant
   
Number of
Options
Outstanding
   
Weighted
Average
Exercise
Price
 
January 1, 2014
   
413
     
1,929
   
$
1.49
 
Options forfeited/cancelled
   
58
     
(58
)
   
1.48
 
December 31, 2014
   
471
     
1,871
   
$
1.48
 
Options granted
   
(131
)
   
131
     
1.92
 
Options forfeited/cancelled
   
207
     
(207
)
   
1.79
 
December 31, 2015
   
547
     
1,795
   
$
1.47
 
Options granted
   
(20
)
   
20
     
2.25
 
Options forfeited/cancelled
   
219
     
(219
)
   
1.72
 
December 31, 2016
   
746
     
1,596
   
$
1.44
 

A summary of LifeMap Solutions’ Equity Incentive Plan activity follows (in thousands except weighted average exercise price):

   
Options
Available
for Grant
   
Number of
Options
Outstanding
   
Weighted
Average
Exercise
Price
 
Option pool added upon incorporation
   
19
     
-
   
$
0.00
 
Options granted
   
(13
)
   
13
     
500.00
 
December 31, 2014
   
6
     
13
   
$
500.00
 
Options granted
   
(2
)
   
2
     
500.00
 
Options forfeited/cancelled
   
1
     
(1
)
   
500.00
 
December 31, 2015
   
5
     
14
   
$
500.00
 
Options granted
   
(2
)
   
2
     
500.00
 
Options forfeited/cancelled
   
4
     
(4
)
   
500.00
 
December 31, 2016
   
7
     
12
   
$
500.00
 

A summary of Cell Cure’s 2007 Employee Share Ownership and Option Plan and 2016 Share Option Plan activity follows (in thousands except weighted average exercise price):

   
Options
Available
for Grant
   
Number of
Options
Outstanding
   
Weighted
Average
Exercise
Price(2)
 
December 31, 2015(1)
   
2
     
12
   
$
23.93
 
Increase to option under 2016 Share Option Plan
   
111
     
-
     
-
 
Options granted
   
(69
)
   
69
     
40.00
 
December 31, 2016
   
44
     
81
   
$
38.00
 

(1)
There was no grant activity during 2014 and 2015.
(2)
Cell Cure Neurosciences Share Option Plan US dollar exercise price shown is approximated based on the conversion rate between the US dollar and the New Israeli Shekel, NIS, at the time of grant.  The exercise price is denominated in NIS.

BioTime Asia had 1,300 stock options available for future grants and 300 stock options outstanding, with a weighted average exercise price of $0.01 per share as of December 31, 2016.
 
95

© Copyright BioTime, Inc.